Your browser doesn't support javascript.
loading
Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
Sekino, Yohei; Sakamoto, Naoya; Goto, Keisuke; Honma, Ririno; Shigematsu, Yoshinori; Quoc, Thang Pham; Sentani, Kazuhiro; Oue, Naohide; Teishima, Jun; Kawakami, Fumi; Karam, Jose A; Sircar, Kanishka; Matsubara, Akio; Yasui, Wataru.
Afiliación
  • Sekino Y; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Sakamoto N; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
  • Goto K; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Honma R; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Shigematsu Y; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Quoc TP; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Sentani K; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
  • Oue N; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Teishima J; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Kawakami F; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Karam JA; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
  • Sircar K; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Matsubara A; Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yasui W; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
BMC Cancer ; 18(1): 952, 2018 Oct 04.
Article en En | MEDLINE | ID: mdl-30286729
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / ARN no Traducido / MicroARNs / Transición Epitelial-Mesenquimal / Neoplasias Renales Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / ARN no Traducido / MicroARNs / Transición Epitelial-Mesenquimal / Neoplasias Renales Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido